Summary: Global News interviews MAPS Canada Chair Mark Haden about MAPS’ ongoing clinical study in Vancouver, BC, focusing on MDMA-assisted psychotherapy as a treatment for posttraumatic stress disorder (PTSD). Haden details how the chemical structure of MDMA may make it ideal for treating PTSD, explains how MDMA-assisted psychotherapy has help many study participants change their relationship with trauma, and highlights published research results.”We are about 5 years away from MDMA being legal [for therapeutic use] in both Canada and the United States,” estimates Haden.
Originally appearing here.
Ecstasy is known as a party drug used at raves, but it could soon also be used as a treatment for post traumatic stress disorder. A team of psychiatrists and psychologists in Vancouver are now running a clinical study to determine whether ecstasy could be an effective treatment for PTSD. Mark Haden, an adjunct professor at UBC’s School of Population and Public Health, joined BC1’s Prime to discuss the study.